No abstract available
MeSH terms
-
Blood-Brain Barrier
-
Clinical Trials as Topic
-
Humans
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use*
-
Leukoencephalopathy, Progressive Multifocal / chemically induced
-
Natalizumab / adverse effects
-
Natalizumab / therapeutic use*
-
Recurrence
Substances
-
Immunosuppressive Agents
-
Natalizumab